A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Non-Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
For this research presented at the 2025 Fall Clinical Dermatology Conference, 98 members of MyPsoriasisTeam living with psoriasis were interviewed to better understand patient-desired outcomes and help dermatologists develop more effective approaches to treatment.
At conversationHEALTH, we have access to first-party data, including physician inquiries across specialties — these are the questions HCPs ask most frequently before they prescribe.